share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4：持股變動聲明-高管 Marriott Tina
美股sec公告 ·  06/04 06:36
牛牛AI助理已提取核心訊息
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 3,000 shares of the company's Class A Common Stock on May 30, 2024. The transaction was carried out on the open market with the shares sold at a price of $8.775 each, resulting in a total market value of $26,325. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 per share. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 3,000 shares of the company's Class A Common Stock on May 30, 2024. The transaction was carried out on the open market with the shares sold at a price of $8.775 each, resulting in a total market value of $26,325. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 per share. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.
Recursion Pharmaceuticals的總裁兼COO Tina Marriott於2024年5月30日出售了3,000股該公司的A級普通股。這筆交易是在公開市場上進行的，股票每股以8.775美元的價格出售，總市值為26,325美元。在此出售之前，Marriott以每股1.06美元的價格行使了同等數量的股份。在交易之後，Marriott在Recursion Pharmaceuticals的直接持股總數為535,457股。
Recursion Pharmaceuticals的總裁兼COO Tina Marriott於2024年5月30日出售了3,000股該公司的A級普通股。這筆交易是在公開市場上進行的，股票每股以8.775美元的價格出售，總市值為26,325美元。在此出售之前，Marriott以每股1.06美元的價格行使了同等數量的股份。在交易之後，Marriott在Recursion Pharmaceuticals的直接持股總數為535,457股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。